A Thy1-CFP DBA/2J mouse line with cyan fluorescent protein expression in retinal ganglion cells

Visual Neuroscience

Volumn 26, Issue 5-6, 2009, Pages 453-465

  Raymond, Iona D ^a   Pool, Angela L ^a   Vila, Alejandro ^b   Brecha, Nicholas C ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

DBA 2J; Fluorescent protein; Ganglion cells; Glaucoma; Transgenic mouse

Indexed keywords

CYAN FLUORESCENT PROTEIN; IMMUNOGLOBULIN; NEURON SPECIFIC NUCLEAR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INTRAOCULAR HYPERTENSION; MICROSATELLITE MARKER; MOUSE; NONHUMAN; OPTIC NERVE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RETINA AMACRINE CELL; RETINA GANGLION CELL; TRANSGENE; TRANSGENIC MOUSE;

AMACRINE CELLS; ANIMALS; ANTIGENS, THY-1; AXONS; BREEDING; GENETIC MARKERS; GLAUCOMA, OPEN-ANGLE; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RECOMBINANT FUSION PROTEINS; RETINAL GANGLION CELLS; SYNTAXIN 1; TRANSCRIPTION FACTOR BRN-3A;

EID: 77951123804     PISSN: 09525238     EISSN: 14698714     Source Type: Journal    
DOI: 10.1017/S095252380999023X     Document Type: Article

References (52)

1. Anderson, M.G., Smith, R.S., Hawes, N.L., Zabaleta, A., Chang, B., Wiggs, J.L. & John, S.W. (2002). Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nature Genetics 30, 81-85.
2. Barnstable, C.J., Hofstein, R.&Akagawa, K. (1985). A marker of early amacrine cell development in rat retina. Brain Research 352, 286-290.
3. Canola, K., Angenieux, B., Tekaya, M., Quiambao, A., Naash, M.I., Munier, F.L., Schorderet, D.F. & Arsenijevic, Y. (2007). Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate. Investigative Ophthalmology & Visual Sciences 48, 446-454.
4. Chang, B., Smith, R.S., Hawes, N.L., Anderson, M.G., Zabaleta, A., Savinova, O., Roderick, T.H., Heckenlively, J.R., Davisson, M.T.& John, S.W. (1999). Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nature Genetics 21, 405-409.
5. Coombs, J., van der List, D., Wang, G.Y. & Chalupa, L.M. (2006). Morphological properties of mouse retinal ganglion cells. Neuroscience 140, 123-136
6. Day, D.A. & Tuite, M.F. (1998). Post-transcriptional gene regulatory mechanisms in eukaryotes: An overview. The Journal of Endocrinology 157, 361-371.
7. Dijk, F., Bergen, A.A. & Kamphuis, W. (2007). GAP-43 expression is upregulated in retinal ganglion cells after ischemia/reperfusion-induced damage. Experimental Eye Research 84, 858-867.
8. Doi, M., Uji, Y. & Yamamura, H. (1995). Morphological classification of retinal ganglion cells in mice. The Journal of Comparative Neurology 356, 368-386.
9. Drager, U.C., Edwards, D.L. & Barnstable, C.J. (1984). Antibodies against filamentous components in discrete cell types of the mouse retina. The Journal of Neuroscience 4, 2025-2042.
10. Drager, U.C. & Hofbauer, A. (1984). Antibodies to heavy neurofilament subunit detect a subpopulation of damaged ganglion cells in retina. Nature 309, 624-626.
11. Dyka, F.M., May, C.A. & Enz, R. (2004). Metabotropic glutamate receptors are differentially regulated under elevated intraocular pressure. Journal of Neurochemistry 90, 190-202.
12. Feng, G., Mellor, R.H., Bernstein, M., Keller-Peck, C., Nguyen, Q.T., Wallace, M., Nerbonne, J.M., Lichtman, J.W. & Sanes, J.R. (2000). Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41-51.
13. Howell, G.R., Libby, R.T., Marchant, J.K., Wilson, L.A., Cosma, I.M., Smith, R.S., Anderson, M.G. & John, S.W. (2007). Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genetics 8, 45.
14. Huang, W., Fileta, J., Guo, Y. & Grosskreutz, C.L. (2006). Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Current Eye Research 31, 265-271.
15. Inman, D.M., Sappington, R.M., Horner, P.J. & Calkins, D.J. (2006). Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Investigative Ophthalmology & Visual Sciences 47, 986-996.
16. Inoue, A. & Akagawa, K. (1993). Neuron specific expression of a membrane protein, HPC-1: Tissue distribution, and cellular and subcellular localization of immunoreactivity and mRNA. Brain Research. Molecular Brain Research 19, 121-128.
17. Inoue, A., Obata, K. & Akagawa, K. (1992). Cloning and sequence analysis of cDNA for a neuronal cell membrane antigen, HPC-1. The Journal of Biological Chemistry 267, 10613-10619.
18. Jakobs, T.C., Libby, R.T., Ben, Y., John, S.W. & Masland, R.H. (2005). Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. The Journal of Cell Biology 171, 313-325.
19. Jeon, C.J., Strettoi, E. & Masland, R.H. (1998). The major cell populations of the mouse retina. The Journal of Neuroscience 18, 8936-8946.
20. John, S.W., Smith, R.S., Savinova, O.V., Hawes, N.L., Chang, B., Turnbull, D., Davisson, M., Roderick, T.H. & Heckenlively, J.R. (1998). Essential iris atrophy, pigment dispersion, and glaucoma in DBA/ 2J mice. Investigative Ophthalmology & Visual Sciences 39, 951-962.
21. Kang, T.H., Ryu, Y.H., Kim, I.B., Oh, G.T. & Chun, M.H. (2004). Comparative study of cholinergic cells in retinas of various mouse strains. Cell and Tissue Research 317, 109-115.
22. Kong, J.H., Fish, D.R., Rockhill, R.L. & Masland, R.H. (2005). Diversity of ganglion cells in the mouse retina: Unsupervised morphological classification and its limits. The Journal of Comparative Neurology 489, 293-310.
23. Kong, W.C.& Cho, E.Y. (1999). Antibodies against neurofilament subunits label retinal ganglion cells but not displaced amacrine cells of hamsters. Life Sciences 64, 1773-1778.
24. Kuehn, M.H., Fingert, J.H. & Kwon, Y.H. (2005). Retinal ganglion cell death in glaucoma: Mechanisms and neuroprotective strategies. Ophthalmology Clinics of North America 18, 383-395, vi.
25. Libby, R.T., Anderson,M.G., Pang, I.H., Robinson, Z.H., Savinova, O.V., Cosma, I.M., Snow, A., Wilson, L.A., Smith, R.S., Clark, A.F. & John, S.W. (2005). Inherited glaucoma in DBA/2J mice: Pertinent disease features for studying the neurodegeneration. Visual Neuroscience 22, 637-648.
26. Moon, J.I., Kim, I.B., Gwon, J.S., Park, M.H., Kang, T.H., Lim, E.J., Choi, K.R. & Chun, M.H. (2005). Changes in retinal neuronal populations in the DBA/2J mouse. Cell and Tissue Research 320, 51-59.
27. Morris, R. (1985). Thy-1 in developing nervous tissue. Developmental Neuroscience 7, 133-160.
28. Morrison, J.C., Johnson, E.C., Cepurna, W. & Jia, L. (2005). Understanding mechanisms of pressure-induced optic nerve damage. Progress in Retinal and Eye Research 24, 217-240.
29. Nickells, R.W. (1996). Retinal ganglion cell death in glaucoma: The how, the why, and the maybe. Journal of Glaucoma 5, 345-356.
30. Nickells, R.W. (1999). Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death. Survey of Ophthalmology 43(Suppl. 1), S151-S161.
31. Quigley, H.A. (1995). Ganglion cell death in glaucoma: Pathology recapitulates ontogeny. Australian and New Zealand Journal of Ophthalmology 23, 85-91.
32. Quigley, H.A. (1996). Number of people with glaucoma worldwide. The British Journal of Ophthalmology 80, 389-393.
33. Quigley, H.A. (1999). Neuronal death in glaucoma. Progress in Retinal and Eye Research 18, 39-57.
34. Quigley, H.A. & Green, W.R. (1979). The histology of human glaucoma cupping and optic nerve damage: Clinicopathologic correlation in 21 eyes. Ophthalmology 86, 1803-1830.
35. Quina, L.A., Pak, W., Lanier, J., Banwait, P., Gratwick, K., Liu, Y., Velasquez, T., O'Leary, D.D., Goulding, M. & Turner, E.E. (2005). Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways. The Journal of Neuroscience 25, 11595-11604.
36. Raymond, I.D., Vila, A., Huynh, U.C. & Brecha, N.C. (2008). CFP expression in ganglion and amacrine cells in a thy1-CFP transgenic mouse retina. Molecular Vision 14, 1559-1574.
37. Reitsamer, H.A., Kiel, J.W., Harrison, J.M., Ransom, N.L. & McKinnon, S.J. (2004). Tonopen measurement of intraocular pressure in mice. Experimental Eye Research 78, 799-804.
38. Ruiz-Ederra, J., Garcia, M., Hicks, D. & Vecino, E. (2004). Comparative study of the three neurofilament subunits within pig and human retinal ganglion cells. Molecular Vision 10, 83-92.
39. Schlamp, C.L., Johnson, E.C., Li, Y., Morrison, J.C. & Nickells, R.W. (2001). Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Molecular Vision 7, 192-201.
40. Schlamp, C.L., Li, Y., Dietz, J.A., Janssen, K.T. & Nickells, R.W. (2006). Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neuroscience 7, 66.
41. Schuettauf, F., Quinto, K., Naskar, R. & Zurakowski, D. (2002). Effects of anti-glaucoma medications on ganglion cell survival: The DBA/2J mouse model. Vision Research 42, 2333-2337.
42. Schuettauf, F., Rejdak, R., Walski, M., Frontczak-Baniewicz, M., Voelker, M., Blatsios, G., Shinoda, K., Zagorski, Z., Zrenner, E. & Grieb, P. (2004). Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathologica (Berlin) 107, 352-358.
43. Soto, I., Oglesby, E., Buckingham, B.P., Son, J.L., Roberson, E.D., Steele, M.R., Inman, D.M., Vetter, M.L., Horner, P.J. & Marsh-Armstrong, N. (2008). Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. The Journal of Neuroscience 28, 548-561.
44. Sun, W., Li, N. & He, S. (2002). Large-scale morphological survey of mouse retinal ganglion cells. The Journal of Comparative Neurology 451, 115-126.
45. Tian, N. & Copenhagen, D.R. (2003). Visual stimulation is required for refinement of ON and OFF pathways in postnatal retina. Neuron 39, 85-96.
46. Voigt, T. (1986). Cholinergic amacrine cells in the rat retina. The Journal of Comparative Neurology 248, 19-35.
47. Wang, X., Ng, Y.K. & Tay, S.S. (2005). Factors contributing to neuronal degeneration in retinas of experimental glaucomatous rats. Journal of Neuroscience Research 82, 674-689.
48. Wang, X., Tay, S.S. & Ng, Y.K. (2000). An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Experimental Brain Research 132, 476-484.
49. Weber, J.T. (1985). Pretectal complex and accessory optic system of primates. Brain, Behavior and Evolution 26, 117-140.
50. Williams, R.W., Strom, R.C., Rice, D.S. & Goldowitz, D. (1996). Genetic and environmental control of variation in retinal ganglion cell number in mice. The Journal of Neuroscience 16, 7193-7205.
51. Wolf, H.K., Buslei, R., Schmidt-Kastner, R., Schmidt-Kastner, P.K., Pietsch, T., Wiestler, O.D. & Blumcke, I. (1996). NeuN: A useful neuronal marker for diagnostic histopathology. The Journal of Histochemistry and Cytochemistry 44, 1167-1171.
52. Xiang, M., Zhou, L., Macke, J.P., Yoshioka, T., Hendry, S.H., Eddy, R.L., Shows, T.B. & Nathans, J. (1995). The Brn-3 family of POU-domain factors: Primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. The Journal of Neuroscience 15(Pt 1), 4762-4785.